The weekly litigation news digest is live. Subscribe now

IP Verse

Dosing Regimens For The Treatment Of Fabry Disease - EP2683382

The patent EP2683382 was granted to Amicus Therapeutics on Apr 22, 2020. The application was originally filed on Mar 8, 2012 under application number EP12758017A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2683382

AMICUS THERAPEUTICS
Application Number
EP12758017A
Filing Date
Mar 8, 2012
Status
Opposition Rejected
Nov 18, 2022
Publication Date
Apr 22, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSJan 21, 2021D YOUNGADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2006153829
DESCRIPTIONUS2010266571
DESCRIPTIONWO9962517
INTERNATIONAL-SEARCH-REPORTUS2006153829
INTERNATIONAL-SEARCH-REPORTUS2010266571
INTERNATIONAL-SEARCH-REPORTUS2010291060
OPPOSITIONUS2006153829
OPPOSITIONUS2010266571
OPPOSITIONUS2010291060
OPPOSITIONWO2008121826
OPPOSITIONWO9962517
SEARCHWO9962517

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents